Cited by 192Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsClinical practice guidelines implementation

The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.

ESC/EAS Guidelines for the management of dyslipidaemias

Catapano, Alberico L., Reiner, Željko, De Backer, Guy, Graham, Ian, Taskinen, Marja-Riitta, Wiklund, Olov, Agewall, Stefan, Alegria, Eduardo, Chapman, M. John, Durrington, Paul, Erdine, Serap, Halcox, Julian, Hobbs, Richard, Kjekshus, John, Perrone Filardi, Pasquale, Riccardi, Gabriele, Storey, Robert F., Wood, David·2011·Atherosclerosis

DOI 10.1016/j.atherosclerosis.2011.06.012

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2011.06.012

Cites

222 of 222 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261

Show all 222 references

Research works printed but not linked: 4

Abumweis SS, Barake R, Jones PJ. Plant sterols/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials. Food Nutr Res 2008;52, doi:10.3402/fnr.v52io.1811. · DOI
2005, Process for the assessment of scientific support for claims on foods: consensus on criteria, Eur J Nutr, 44, I/5
Poulter, 1999, The impact of micronized fenofibrate on lipid subfractions and on reaching HDL-target levels in 7,098 patients with dyslipidaemia, Br J Cardiol, 6, 682
DeMott K, Nherera L, Shaw EJ, Minhas R, Humphries SE, Kathoria M, Ritchie G, Nunes V, Davies D, Lee P, McDowell I, Neil A, Qureshi N, Rowlands P, Seed M, Stracey H, Thorogood M, Watson M. Clinical guidelines and evidence review for familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners; 2008.

Sorted by citations

European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,865
Self-citation
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Authors Task Force Members, Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,994
Self-citation
Effects of extended-release niacin with laropiprant in high-risk patients
The HPS2-THRIVE Collaborative Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1300955 · Cited by 1,668
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665
Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
Anderson, T. J., Grégoire, J. C., Hegele, R. A., Couture, P., Mancini, G. B. J., McPherson, R., Francis, G. A., Poirier, P., Lau, D. C. W., Grover, S. A., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.11.032 · Cited by 780
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
Hegele, R. A., Ginsberg, H. N., Chapman, M. J., Nordestgaard, B. G., Kuivenhoven, J. A., Averna, M., Borén, J., Bruckert, E., Catapano, A. L., Descamps, O. S., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70191-8 · Cited by 635
Self-citation
Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication
Benn, M., Watts, G. F., Tybjaerg-Hansen, A., & Nordestgaard, B. G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1563 · Cited by 632
Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|^mdash;2012 Version
Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., Dohi, S., Egusa, G., Hiro, T., Hirobe, K., Iida, M., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.15792 · Cited by 468
The prevalence, awareness, treatment and control of dyslipidemia among adults in China
Pan, L., Yang, Z., Wu, Y., Yin, R., Liao, Y., Wang, J., Gao, B., & Zhang, L. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.006 · Cited by 402
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – Summary
pre-diabetes Task Force on diabetes (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114525548 · Cited by 239
Lipid-modifying effects of nutraceuticals: An evidence-based approach
Sahebkar, A., Șerban, M.-C., Gluba-Brzózka, A., Mikhailidis, D. P., Cicero, A. F. G., Rysz, J., & Banach, M. (2016) · Nutrition · doi:10.1016/j.nut.2016.04.007 · Cited by 188
Serum triglycerides and risk of cardiovascular disease
Boullart, A. C. I., Graaf, J. D., & Stalenhoef, A. F. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.002 · Cited by 159
Role of Nutrition in the Pathogenesis and Prevention of Non-alcoholic Fatty Liver Disease: Recent Updates
Ullah, R., Rauf, N., Nabi, G., Ullah, H., Shen, Y., Zhou, Y., & Fu, J. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.30121 · Cited by 162
Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance
Baratta, F., Pastori, D., Polimeni, L., Bucci, T., Ceci, F., Calabrese, C. M., Ernesti, I., Pannitteri, G., Violi, F., Angelico, F., et al. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.371 · Cited by 151
Phytosterols, Phytostanols, and Lipoprotein Metabolism
Gylling, H., & Simonen, P. P. (2015) · Nutrients · doi:10.3390/nu7095374 · Cited by 140
Metabolic Syndrome and Male Fertility
Martins, A. D., Majzoub, A. A., & Agawal, A. (2018) · The World Journal of Men s Health · doi:10.5534/wjmh.180055 · Cited by 119
Transport, metabolism and remedial potential of functional food extracts (FFEs) in Caco-2 cells monolayer: A review
Iftikhar, M., Iftikhar, A., Zhang, H., Gong, L., & Wang, J. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109240 · Cited by 103
Carotid Plaque Characteristics and Disease Activity in Rheumatoid Arthritis
Semb, A. G., Rollefstad, S., Provan, S. A., Kvien, T. K., Stranden, E., Olsen, I. C., & Hisdal, J. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.120621 · Cited by 102
HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom
France, M. W., Rees, A., Datta, D. B. N., Thompson, G. R., Capps, N. E., Ferns, G. A., Ramaswami, U., Seed, M., Neely, D., Cramb, R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.017 · Cited by 104
Self-citation
Management of residual risk after statin therapy
Reith, C. A., & Armitage, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.12.018 · Cited by 91
Intensive LDL-cholesterol lowering therapy and neurocognitive function
Banach, M., Rizzo, M., Nikolić, D., Howard, G., Howard, V. J., & Mikhailidis (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.001 · Cited by 68
Cardiovascular risk prediction in HIV ‐infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score ( ASCVD ), Systematic Coronary Risk Evaluation for the N etherlands (SCORE ‐ NL) and Data Collection on Adverse Events of Anti‐ HIV Drugs ( D : A : D ) risk prediction models
Krikke, M., Hoogeveen, R., Hoepelman, A. I. M., Visseren, F. L. J., & Arends, J. (2015) · HIV Medicine · doi:10.1111/hiv.12300 · Cited by 63
Nonstatin Low-Density Lipoprotein–Lowering Therapy and Cardiovascular Risk Reduction—Statement From ATVB Council
Hegele, R. A., Gidding, S. S., Ginsberg, H. N., McPherson, R., Raal, F. J., Rader, D. J., Robinson, J. G., & Welty, F. K. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.306442 · Cited by 63
Identification and management of patients with statin-associated symptoms in clinical practice: A clinician survey
Hovingh, G. K., Gandra, S. R., McKendrick, J., Dent, R. E., Wieffer, H., Catapano, A. L., OH, P. I., Rosenson, R. S., & Stroes, E. S. G. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.12.015 · Cited by 62
Self-citation
Omega-3 Polyunsaturated Fatty Acids: Structural and Functional Effects on the Vascular Wall
Zanetti, M., Grillo, A., Losurdo, P., Panizon, E., Mearelli, F., Cattin, L., Barazzoni, R., & Carretta, R. (2015) · BioMed Research International · doi:10.1155/2015/791978 · Cited by 59
Lemon balm: A promising herbal therapy for patients with borderline hyperlipidemia—A randomized double-blind placebo-controlled clinical trial
Jandaghi, P., Noroozi, M., Ardalani, H., & Alipour, M. (2016) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2016.03.012 · Cited by 54
Lipid lowering drugs and the risk of recurrent venous thromboembolism
Delluc, A., Tromeur, C., Moigne, E. L., Nowak, E., Mottier, D., Gal, G. L., & Lacut, K. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.08.296 · Cited by 53
Multicenter Study to Determine the Diagnosis Criteria of Heterozygous Familial Hypercholesterolemia in Japan
Harada‐Shiba, M., Arai, H., Okamura, T., Yokote, K., Oikawa, S., Nohara, A., Okada, T., Ohta, T., Bujo, H., Watanabe, M., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14159 · Cited by 50
Is lower and lower better and better? A re-evaluation of the evidence from the Cholesterol Treatment Trialists’ Collaboration meta-analysis for low-density lipoprotein lowering
Sniderman, A. D., Thanassoulis, G., Couture, P., Williams, K., Alam, A., & Furberg, C. D. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.05.004 · Cited by 49
Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols, and Berberine) in Patients with Low-Moderate Risk Hypercholesterolemia: A Double-Blind, Placebo-Controlled Study
Gonnelli, S., Caffarelli, C., Stolakis, K., Cuda, C., Giordano, N. G., & Nuti, R. (2014) · Current Therapeutic Research · doi:10.1016/j.curtheres.2014.07.003 · Cited by 49
Prevalence of familial hypercholesterolemia: a meta-analysis of six large, observational, population-based studies in Poland
Pająk, A., Szafraniec, K., Polak, M., Drygas, W., Piotrowski, W., Zdrojewski, T. R., & Jankowski, P. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.59700 · Cited by 48
A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids
Karalis, D. G. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0462-y · Cited by 48
Monitoring of lipids, enzymes, and creatine kinase in patients on lipid-lowering drug therapy
Wiklund, O., Pirazzi, C., & Romeo, S. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0397-8 · Cited by 45
Self-citation
Management of lipid disorders in patients living with HIV
Myerson, M. L., Malvestutto, C., & Aberg, J. A. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.473 · Cited by 44
Observational study to evaluate the safety and efficacy of saroglitazar in Indian diabetic dyslipidemia patients
Shetty, S., Kumar, S., Mathur, R. P., Sharma, K. H., & Jaiswal, A. D. (2015) · Indian Heart Journal · doi:10.1016/j.ihj.2015.02.007 · Cited by 45
Glycated hemoglobin-detection methods based on electrochemical biosensors
Yazdanpanah, S., Rabiee, M., Tahriri, M., Abdolrahim, M., & Tayebi, L. (2015) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2015.03.019 · Cited by 43
What to say and how to say it
Návar, A. M., Stone, N. J., & Martin, S. S. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000322 · Cited by 43
PROMETHEUS: an observational, cross-sectional, retrospective study of hypertriglyceridemia in Russia
IuA, K., & Владиславовна, Х. Ю. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0268-2 · Cited by 42
The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus
Protogerou, A. D., Fransen, J., Zampeli, E., Argyris, A., Aissopou, E., Arida, A., Konstantonis, G. D., Tentolouris, N., Makrilakis, K., Psichοgiou, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132307 · Cited by 41
Usefulness of Patients-Reported Outcomes in Rheumatoid Arthritis Focus Group
Amaya‐Amaya, J., Corzo, D. B., Calixto, O.-J., Calderon-Rojas, R. D., Domínguez, A. R., Cruz‐Tapias, P., Montoya-Ortiz, G., Mantilla, R.-D., Anaya, J., & Rojas‐Villarraga, A. (2012) · Arthritis · doi:10.1155/2012/935187 · Cited by 42
A spread containing bioactive milk peptides Ile–Pro–Pro and Val–Pro–Pro, and plant sterols has antihypertensive and cholesterol-lowering effects
Turpeinen, A. M., Ikonen, M., Kivimäki, A. S., Kautiainen, H., Vapaatalo, H., & Korpela, R. (2012) · Food & Function · doi:10.1039/c2fo10286b · Cited by 41
Dietary cholesterol and egg yolk should be avoided by patients at risk of vascular disease
Spence, J. D. (2016) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2016-0005 · Cited by 38
Antioxidant and hypolipidemic effects of soymilk fermented via Lactococcus acidophilus MF204
Chen, J., Wu, Y., Yang, C., Xu, X., & Meng, Y. (2017) · Food & Function · doi:10.1039/c7fo00701a · Cited by 38
ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I
Ахмеджанов, Н. М., Небиеридзе, Д. В., Safaryan, A. S., Выгодин, В. А., Shuraev, A. Y., Tkacheva, O. N., & Лишута, А. С. (2015) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2015-11-3-253-260 · Cited by 36
Therapeutic Potential of Mipomersen in the Management of Familial Hypercholesterolaemia
Gelsinger, C., Steinhagen‐Thiessen, E., & Kassner, U. (2012) · Drugs · doi:10.2165/11635060-000000000-00000 · Cited by 35
Statin therapy is associated with reduced incidence of hypoxic hepatitis in critically ill patients
Drolz, A., Horvatits, T., Michl, B., Roedl, K., Schellongowski, P., Holzinger, U., Zauner, C., Heinz, G., Madl, C., Trauner, M. A., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.019 · Cited by 35
Pathophysiological mechanisms of statin‐associated myopathies: possible role of the ubiquitin‐proteasome system
Sahebkar, A., Cicero, A. F. G., Giosia, P. D., Pomilio, I., Stamerra, C. A., Giorgini, P., Ferri, C., von Haehling, S., Banach, M., & Jamialahmadi, T. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12579 · Cited by 33
Landmark Lipid‐Lowering Trials in the Primary Prevention of Cardiovascular Disease
Chrispin, J., Martin, S. S., Hasan, R. K., Joshi, P. H., Minder, C. M., McEvoy, J. W., Kohli, P., Johnson, A. E., Wang, L., Blaha, M. J., et al. (2013) · Clinical Cardiology · doi:10.1002/clc.22147 · Cited by 36
Risk burdens of modifiable risk factors incorporating lipoprotein (a) and low serum albumin concentrations for first incident acute myocardial infarction
Yang, Q., He, Y., Cai, D.-P., Yang, X., & Xu, H. (2016) · Scientific Reports · doi:10.1038/srep35463 · Cited by 32
Effect of hazelnut on serum lipid profile and fatty acid composition of erythrocyte phospholipids in children and adolescents with primary hyperlipidemia: A randomized controlled trial
Deon, V., Bo’, C. D., Guaraldi, F., Abello, F., Belviso, S., Porrini, M., Riso, P., & Guardamagna, O. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.05.022 · Cited by 32
How to balance cardiorenometabolic benefits and risks of statins
Lim, S. K., Oh, P. C., Sakuma, I., & Koh, K. K. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.06.001 · Cited by 31
Gene silencing approaches for the management of dyslipidaemia
Norata, G. D., Tibolla, G., & Catapano, A. L. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.010 · Cited by 30
Self-citation
Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection
Julius, U. (2016) · Medical Devices Evidence and Research · doi:10.2147/mder.s98889 · Cited by 29
Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study
Yamashita, S., Masuda, D., Harada‐Shiba, M., Arai, H., Bujo, H., Ishibashi, S., Daida, H., Koga, N., & Oikawa, S. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.62764 · Cited by 29
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients
Bocchia, M., Galimberti, S., Aprile, L., Sicuranza, A., Gozzini, A., Santilli, F., Abruzzese, E., Baratè, C., Scappini, B., Fontanelli, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11100 · Cited by 29
Vascular effects of nonsteroidal antiinflammatory drugs
Soubrier, M., Rosenbaum, D. H., Tatar, Z., Lahaye, C., Dubost, J., & Mathieu, S. (2013) · Joint Bone Spine · doi:10.1016/j.jbspin.2012.12.002 · Cited by 28
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial
Brinton, E. A., Kher, U. A., Shah, S., Cannon, C. P., Davidson, M. H., Gotto, A. M., Ashraf, T. B., Sisk, C. M., Dansky, H. M., Mitchel, Y., et al. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.10.005 · Cited by 27
Self-citation
Bariatric surgery and cardiovascular outcome
Ammar, W., Basset, H. A., Faramawy, A. E., Hegazy, T. O., & Sharaf, Y. (2020) · The Egyptian Heart Journal · doi:10.1186/s43044-020-00096-8 · Cited by 27
Risk of Acute Myocardial Infarction
Madssen, E., Laugsand, L. E., Wiseth, R., Mørkedal, B., Platou, C., VATTEN, L. J., & Janszky, I. (2013) · Epidemiology · doi:10.1097/ede.0b013e31829d2632 · Cited by 28
Postprandial dyslipidaemia and diabetes
Pang, J., Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328354c790 · Cited by 29
Prevalence and management of hypercholesterolemia in France, the Esteban observational study
Blacher, J., Gabet, A., Vallée, A., Ferrières, J., Bruckert, É., Farnier, M., & Olié, V. (2020) · Medicine · doi:10.1097/md.0000000000023445 · Cited by 30
Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy
Lorenzi, M. F., Ambegaonkar, B. M., Baxter, C. A., Jansen, J. P., Zoratti, M. J., & Davies, G. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1379-z · Cited by 26
The TELE-DD Randomised Controlled Trial on Treatment Adherence in Patients with Type 2 Diabetes and Comorbid Depression: Clinical Outcomes after 18-Month Follow-Up
del Hoyo, M. L. L., Fernández‐Rodrigo, M. T., Urcola‐Pardo, F., Monreal‐Bartolomé, A., Ruiz, D. C. G., Borao, M. G., Alcázar, A. B. A., Casbas, J. P. M., Casas, A. A., Funcia, M. T. A., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010328 · Cited by 27
ApoB versus non-HDL-cholesterol: Diagnosis and cardiovascular risk management
de Nijs, T., Sniderman, A. D., & Graaf, J. D. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.847897 · Cited by 25
Superior role of waist circumference to body-mass index in the prediction of cardiometabolic risk in dyslipidemic patients.
Cibičková, Ľ., Langová, K., Vaverkova, H., Lukeš, J., Cibiček, N., & Karásek, D. (2019) · Physiological Research · doi:10.33549/physiolres.934176 · Cited by 16
Atherosclerosis: Comparative Pathogenesis, Lipoprotein Metabolism, and Avian and Exotic Companion Mammal Models
Beaufrère, H. (2013) · Journal of Exotic Pet Medicine · doi:10.1053/j.jepm.2013.10.016 · Cited by 23
Evaluation of plasma PCSK9 concentrations, transcript of LDL receptor, as well as the total number of monocyte LDL receptors in acute coronary syndrome patients
Burchardt, P., Rzeźniczak, J., Dudziak, J., Dżumak, A., Marchlewski, T., Ganowicz-Kaatz, T., Popiak, M., Słomczyński, M., Jezierski, M., Laskowski, W., et al. (2016) · Cardiology Journal · doi:10.5603/cj.a2016.0068 · Cited by 22
Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper.
Sabouret, P. F., Lemesle, G., Bellemain-Appaix, A., Aubry, P., Bocchino, P.-P., Rafflenbeul, E., Belle, L., Nolan, J., Bernardi, M., Biondi‐Zoccai, G., et al. (2022) · Archives of Medical Science · doi:10.5114/aoms/150321 · Cited by 25
LOX-1 ligands containing apolipoprotein B and carotid intima-media thickness in middle-aged community-dwelling US Caucasian and Japanese men
Okamura, T., Sekikawa, A. M., Sawamura, T., Kadowaki, T., Barinas‐Mitchell, E., Mackey, R. H., Kadota, A., Evans, R. G., Edmundowicz, D., Higashiyama, A., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.04.023 · Cited by 21
LDL Cholesterol Goals in High-Risk Patients: How Low Do We Go and How Do We Get There?
Besseling, J., van Capelleveen, J. C., Kastelein, J. J. P., & Hovingh, G. K. (2013) · Drugs · doi:10.1007/s40265-013-0028-0 · Cited by 21
Increased chitotriosidase activity in plasma of patients with type 2 diabetes
Żurawska-Płaksej, E., Knapik-Kordecka, M., Rorbach-Dolata, A., & Piwowar, A. (2016) · Archives of medical science : AMS · doi:10.5114/aoms.2016.60093 · Cited by 19
TG/HDL-C Ratio Is a Risk Factor Associated with CKD: Use in Assessing the Risk of Progression of CKD
Ha, N. H., Tran, H. H., Nguyen, L. T., Nguyen, T. N., Nguyen, N. A., Vi, M. T., & Nguyen, K. T. (2022) · Pathophysiology · doi:10.3390/pathophysiology29030029 · Cited by 19
Do all lupus patients need statins?
Soubrier, M., Mathieu, S., Hermet, M., Makarawiez, C., & Bruckert, É. (2012) · Joint Bone Spine · doi:10.1016/j.jbspin.2012.08.014 · Cited by 18
Diabetes Mellitus
Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., Dohi, S., Egusa, G., Hiro, T., Hirobe, K., Iida, M., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.19349 · Cited by 18
Reproducibility of Cutaneous Vascular Conductance Responses to Slow Local Heating Assessed Using seven‐Laser Array Probes
Dawson, E. A., Low, D. A., Meeuwis, I. H. M., Kerstens, F. G., Atkinson, C. L., Cable, N. T., GREEN, D. J., & Thijssen, D. H. J. (2015) · Microcirculation · doi:10.1111/micc.12196 · Cited by 18
Difference between calculated and direct-measured low-density lipoprotein cholesterol in subjects with diabetes mellitus or taking lipid-lowering medications
Choi, S., Park, H. E., Kim, M. K., Shin, C. S., Cho, S., & Oh, B. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.12.007 · Cited by 18
Efficacy of Plant Sterol-Enriched Food for Primary Prevention and Treatment of Hypercholesterolemia: A Systematic Literature Review
Turini, E., Sarsale, M., Petri, D., Totaro, M., Lucenteforte, E., Tavoschi, L., & Baggiani, A. (2022) · Foods · doi:10.3390/foods11060839 · Cited by 17
Prevalence of persistent lipid abnormalities in statin‐treated patients: Belgian results of the Dyslipidaemia International Study ( DYSIS )
Devroey, D., Radermecker, R. P., der Schueren, B. V., Torbeyns, B., & Jaken, R. J. P. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12315 · Cited by 17
Predictive Value of Adiponectin in Patients with Multivessel Coronary Atherosclerosis Detected on Computed Tomography Angiography
Matsuda, M., Tamura, R., Kishida, N., Segawa, T., Kanno, K., Nishimoto, O., Nakamoto, K., Nishiyama, H., & Kawamoto, T. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.18036 · Cited by 17
Management standards for stable coronary artery disease in India
Mishra, S., Ray, S., Dalal, J. J., Sawhney, J. P. S., Ramakrishnan, S., Nair, T., Iyengar, S. S., & Bahl, V. K. (2016) · Indian Heart Journal · doi:10.1016/j.ihj.2016.11.320 · Cited by 17
Potential Effects of Reclassifying CKD as a Coronary Heart Disease Risk Equivalent in the US Population
Foster, M. C., Rawlings, A. M., Marrett, E., Neff, D., Grams, M. E., Kasiske, B. L., Willis, K., Inker, L. A., Coresh, J., & Selvin, E. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.11.014 · Cited by 16
Intensive risk factor control in stroke prevention
Spence, J. D. (2013) · F1000Prime Reports · doi:10.12703/p5-42 · Cited by 17
Metabolic syndrome and coronary artery disease in adults with congenital heart disease
Niwa, K. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-781 · Cited by 16
A Mobile Health-Based Disease Management Program Improves Blood Pressure in People With Multiple Lifestyle-Related Diseases at Risk of Developing Vascular Disease ― A Retrospective Observational Study ―
Kanai, M., Toda, T., Yamamoto, K., Akimoto, M., & Hagiwara, Y. (2022) · Circulation Reports · doi:10.1253/circrep.cr-22-0024 · Cited by 14
Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge
Rysz, J., Gluba-Brzózka, A., Banach, M., & Więcek, A. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-0937-9 · Cited by 14
Primary Hypertriglyceridemia: A Look Back on the Clinical Classification and Genetics of the Disease
Musambil, M., Al-Rubeaan, K. A., Al-Qasim, S., Alnaqeb, D., & Al-Soghayer, A. (2020) · Current Diabetes Reviews · doi:10.2174/1573399815666190502164131 · Cited by 16
Hipercolesterolemia familiar: artículo de revisión
Merchán, A., Ruiz, Á. J., Campo, R., Prada, C. E., Toro, J. M., Sánchez, R., Gómez‐Mesa, J. E., Jaramillo, N. I., Molina, D. I., Vargas‐Uricoechea, H., et al. (2016) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.05.002 · Cited by 18
Statin-associated muscle symptoms (SAMS) in primary prevention for cardiovascular disease in older adults: a protocol for a systematic review and meta-analysis of randomised controlled trials
Zhou, Z., Albarqouni, L., Breslin, M. C., Curtis, A. J., & Nelson, M. R. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017587 · Cited by 13
Strategies for screening for familial hypercholesterolaemia in primary care and other community settings
Qureshi, N., Silva, M. L. R. D., Abdul-Hamid, H., Weng, S. F., Kai, J., & Leonardi‐Bee, J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012985.pub2 · Cited by 18
Clinical Impact of Rapid Reduction of Low-Density Lipoprotein Cholesterol Level on Long-Term Outcome of Acute Myocardial Infarction in the Statin Era: Subanalysis of the ALPS-AMI Study
Miura, T., Izawa, A., Motoki, H., Miyashita, Y., Kashima, Y., Ebisawa, S., Tomita, T., Koyama, J., & Ikeda, U. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127835 · Cited by 13
The curative treatment of familial hypercholesterolemia: Liver transplantation
Kirnap, N. G., Kırnap, M., Tütüncü, N. B., Moray, G., & Haberal, M. A. (2019) · Clinical Transplantation · doi:10.1111/ctr.13730 · Cited by 13
Combined Treatment with Amlodipine and Atorvastatin Calcium Reduces Circulating Levels of Intercellular Adhesion Molecule-1 and Tumor Necrosis Factor-α in Hypertensive Patients with Prediabetes
Huang, Z., Chen, C., Li, S., Kong, F., Shan, P., & Huang, W. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00206 · Cited by 12
Persistent lipid abnormalities in statin-treated coronary artery disease patients with and without diabetes in China
Wei, Y., Guo, H., The, E., Che, W., Shen, J., Hou, L., Zhao, S., Ye, P., Li, G., Wang, D., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.01.024 · Cited by 13
Cardiovascular risk factor control is insufficient in young patients with coronary artery disease
Christiansen, M. K., Jensen, J. M., Broendberg, A. K., Bøtker, H. E., & Jensen, H. K. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s106436 · Cited by 11
Double product reflects the association of heart rate with MACEs in acute coronary syndrome patients treated with percutaneous coronary intervention
Xu, T., Zhan, Y., Lu, N., He, Z., Su, X., & Tan, X. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0714-z · Cited by 10
Effectiveness of a diet with low advanced glycation end products, in improving glycoxidation and lipid peroxidation: a long-term investigation in patients with chronic renal failure
Chilelli, N. C., Cremasco, D., Cosma, C., Ragazzi, E., Pesenti, F. F., Bonfante, L., & Lapolla, A. (2015) · Endocrine · doi:10.1007/s12020-015-0805-5 · Cited by 10
Optimal Use of Plant Stanol Ester in the Management of Hypercholesterolemia
Rosin, S., Ojansivu, I. T., Kopu, A., Keto-Tokoi, M., & Gylling, H. (2015) · Cholesterol · doi:10.1155/2015/706970 · Cited by 10
Non-High-Density Lipoprotein Cholesterol Levels on the Risk of Asymptomatic Intracranial Arterial Stenosis: A Result from the APAC Study
Wu, J., Wang, A., Li, X., Wu, S., & Zhao, X. (2016) · Scientific Reports · doi:10.1038/srep37410 · Cited by 10
Rationale and design of a randomized clinical study to investigate the effect of ezetimibe, a cholesterol absorption inhibitor, on the regression of intracoronary plaque evaluated by non-obstructive angioscopy and ultrasound: The ZIPANGU study
Hiro, T., Hirayama, A., Ueda, Y., Komatsu, S., Matsuoka, H., Takayama, T., Ishihara, M., Hayashi, T., Saito, S., & Kodama, K. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2014.02.026 · Cited by 10

Authors: Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., Erdine, S., Halcox, J., Hobbs, R., Kjekshus, J., Perrone Filardi, P., Riccardi, G., Storey, R. F., & Wood, D.
Corresponding author: Catapano, Alberico L.
Reiner, Željko
ORCID: Catapano, Alberico L.
Reiner, Željko
Graham, Ian
Taskinen, Marja-Riitta
Wiklund, Olov
Agewall, Stefan
Chapman, M. John
Durrington, Paul
Erdine, Serap
Halcox, Julian
Hobbs, Richard
Kjekshus, John
Storey, Robert F.
Wood, David
Venue: Atherosclerosis
Publisher: Elsevier BV
Published: 2011-07
Volume: 217
Pages: 1-44
ISSN: 0021-9150 (ISSN-L)
DOI: 10.1016/j.atherosclerosis.2011.06.012
OpenAlex: W4210968492
Cited by: 192
References: 222
Citations by year: 2026: 3 · 2025: 1 · 2023: 7 · 2022: 12 · 2021: 11 · 2020: 11 · 2019: 6 · 2018: 8 · 2017: 13 · 2016: 29 · 2015: 27 · 2014: 10 · 2013: 34 · 2012: 16
FWCI: 3.63
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Atherosclerosis (publishedVersion)
PubMed (publishedVersion)
ORBi (University of Liège) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Keywords: dyslipidemia, dyslipidemia management, lipid-lowering therapy, cardiovascular risk, risk-benefit assessment, clinical guidelines
MeSH terms: Adolescent, Adult, Aged, Cardiology, Cardiovascular Diseases, Child, Cholesterol, Clinical Trials as Topic, Europe, Female, Genotype, Humans, Life Style, Lipids, Lipoproteins, Male, Middle Aged, Societies, Medical, Practice Guidelines as Topic, Dyslipidemias, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

ESC/EAS Guidelines for the management of dyslipidaemias

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks